公司資料
SpringWorks Therapeutics 股價、新聞與催化劑
- 股票代碼:
- SWTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for SWTX.
公司概覽
業務概覽
SpringWorks Therapeutics is a rare-disease and oncology biotech focused on targeted treatments for genetically defined conditions. Its story blends commercial execution with a highly focused pipeline.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, SpringWorks sits in specialty biopharma.
商業模式特徵
The company combines product revenue with pipeline development, so investors watch launch progress, label expansion, and regulatory milestones.
生技產業定位
SpringWorks is a focused specialty-biotech name whose stock can move sharply on data and commercial milestones.
未來催化劑
- SpringWorks's catalysts are nirogacestat in desmoid tumors and mirdametinib in NF1-PN, both of which can move the stock if commercial and late-stage execution stay clean. The company is still building its rare-disease franchise.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。